Research peptide reagents
One maker. Every lot on record.
STAQS supplies research-grade peptide reagents as sealed dual-chamber reconstitution sets, each one with its compound, purity, and batch on record. Numbers over adjectives.
⚠ For research use only — not for human or veterinary use.
The problem with most "research peptides"
You can't run a clean experiment on a mystery powder.
Most of this market ships unlabelled vials and a vibe. No purity figure you can cite. No batch you can trace. No maker who'll put their name to the lot. Batch-to-batch, you're guessing. And your data inherits the guess. We think that's a problem worth being annoyed about.
Unverifiable purity
A figure you can't cite isn't a figure. If a purity number isn't tied to the lot, it isn't on record.
No maker, just a middleman.
A re-bottler can't tell you who made the powder, because it wasn't them. The difference shows up at peer review.
Identity drift
No CAS, no batch overprint, no traceability. The vial in front of you may not match the one before it.
Every undocumented input is a confound you pay for later: in re-runs, in reviewer questions, in time you don't get back.
If your last batch behaved differently than the one before, the variable may have been the vial. That's not on you.
What STAQS does
We do the boring part properly, so your variable is the compound, not the vial.
Every STAQS reagent is a sealed dual-chamber reconstitution set: lyophilised compound and diluent in one vial, reconstituted in-vial in the lab. Each set carries a purity figure (HPLC), a CAS identifier, and a net-content statement: the same facts on the carton, on the vial, and on record. One maker stands behind every one of them.
We don't sell outcomes. We sell a documented reagent you can cite.
Ondermax Ltd (United Kingdom), merchant of record. Stored and shipped cold (2–8 °C). Every figure printed is the lot's own.
What's on record for every lot
Documented so you can cite it.
≥0% (HPLC), on record for every lot.
CAS identifier + peptide-structure schematic on every carton.
Stated per vial: a neutral net-content figure, never a dose.
Traceable to the one maker who produced it: every lot, on record.
Schematic, not to scale. Every figure is the lot's own.
How a preorder works
Four steps. No payment taken until you have an invoice.
Pick your reagent and destination.
Confirm the research-use attestation.
We review and issue a stablecoin invoice with the quoted amount.
Pay in stablecoin; we dispatch and you can trace the lot.
We acknowledge your request and issue your invoice within 24h. Refunds follow the stated guarantee policy.
The catalogue
Each reagent documented to the lot.
Specification on request. One maker behind every lot.
The format
A dual-chamber reconstitution set: lab prep, by design.
Powder and diluent arrive sealed in one vial. In the lab you engage the bypass to twist-to-reconstitute, swirl until dissolved, then aliquot and store cold (2–8 °C). It's laboratory preparation equipment: nothing more, and we won't dress it up as anything more.
Phase 01
Inspect
Check vial, lot, use-by; confirm cake + diluent.
Phase 02
Activate
Depress top stopper; diluent passes the bypass into the lower chamber.
Phase 03
Reconstitute
Swirl gently until dissolved; do not shake.
Phase 04
Aliquot · store
Withdraw with a sterile laboratory tip; aliquot; store 2–8 °C.
Illustration of laboratory reconstitution only: engage bypass › swirl › aliquot › store cold (2–8 °C). Not a recommendation to administer to humans.
The documentation spine, beat by beat.
With a reagent whose purity and batch are on paper, not on trust.
If your last batch behaved differently than the one before, that's not on you.
Purity by HPLC, CAS on the carton, the maker on record. Check it against the lot in your hand.
You suspected it. It was.
It's re-bottlers who hide behind batch variability and can't name who made the powder. We make it. Every lot on record.
For researchers who want the maker on the line.
Built for researchers who want one maker behind the vial and every lot on record. If that's you, the bench is open.
We're early, we're exacting, and we'd rather point at the lot than make you a promise.